Hydroxystenozole
Hydroxystenozole, also known as 17α-methylandrost-4-enopyrazol-17β-ol, is an orally active androgen/anabolic steroid and a 17α-alkylated derivative of testosterone that was described in the literature in 1967 but was never marketed. It is closely related to stanozolol, differing from it only in hydrogenation.
